FASN and pancreatic neoplasm: EGFR signalling upregulates FASN expression in pancreatic cancer cells (Bian et al., 2015), and SREBF1 (Ali et al., 2018; Chen et al., 2021; Luo et al., 2021; Xu et al., 2021), FASN (Ali et al., 2018; Chen et al., 2021; Xu et al., 2021), and SCD1 (Xu et al., 2021; J. Zhang et al., 2017a) expression in NSCLC cells.